1. 1 |1 | Countries using and planning to introduce IPV and the global status of bOPV registration Countries using and planning to introduce IPV and the global status of bOPV registration

2. 2 |2 | Countries using and planning to introduce IPV January 2016 status report This slide deck provides a summary per country on the status of planning for the introduction of Inactivated Poliomyelitis Vaccine (IPV). It also includes a summary of the global status of national registration of bivalent Oral Polio Vaccine (bOPV), in preparation for the switch from trivalent OPV (tOPV) to bOPV. Information here is updated monthly based on information shared by WHO and UNICEF Regional Offices. Please contact polio2@who.int with any questions or updates on this data.polio2@who.int Definitions Formal decision to introduce: The country has documentation of its decision to introduce IPV which has been verified by the relevant WHO Regional Office, or for Gavi eligible countries, a complete application for IPV has been submitted to the Gavi Secretariat. Intent to introduce: The country has informally indicated that it plans to introduce IPV, e.g. planning an application to Gavi, or by requesting technical assistance to develop an IPV introduction plan. Tracking these decisions and informal intents provide an indication of the global trend towards meeting the targets of the Polio Eradication and Endgame Strategic Plan.

3. 3 |3 | Countries using IPV vaccine to date and formal decision to introduce Data source: WHO/IVB Database, as of 07 January 2016 Map production Immunization Vaccines and Biologicals (IVB), World Health Organization Date of slide: 7 January 2016 The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2016. All rights reserved. Introduced to date(149 countries or 77%) (45 countries or 23%) Formal commitment to introduce in 2016 Not available Not applicable Since January 2013, the following countries have introduced IPV: Kazakhstan, Peru & Singapore (July 2013); Micronesia (August 2013); Libya (April 2014); Albania & Panama (May 2014); Nepal & Tunisia (September 2014); Philippines (October 2014); China (December 2014); Comoros, Senegal & Serbia (January 2015); Colombia & Nigeria (February 2015); Bangladesh & Maldives (March 2015); DR Congo, DPR Korea & The Gambia (April 2015); Madagascar (May 2015); Cote d'Ivoire, Grenada, Kiribati, Morocco, St Vincent and the Grenadines & Sudan (June 2015); Bhutan, Cameroon, Niger, Pakistan, Philippines & Sri Lanka (July 2015); Benin, Chad, Papua New Guinea, The Former Yug. Rep. of Macedonia (August 2015); Afghanistan, CAR, Dominica, Guyana, Iran, Jamaica, Seychelles & Solomon Islands (September 2015); Bahamas, Lao People's Dem Rep, Nauru, Samoa (October 2015); Antigua and Barbuda, Botswana, Burundi, Cook Islands, Guinea, India, Mauritania, Mauritius, Mozambique, Namibia, Nicaragua, St Lucia, Suriname, Tuvalu, Vanuatu & Yemen (November 2015); Algeria, Belize, Cambodia, Dominical Rep, Ecuador, Ethiopia, Fiji, Gabon, Georgia, Honduras, Kenya, Myanmar, S. Sudan, Thailand, Tonga & Trinidad & Tobago (December 2015)

4. 4 |4 | Countries using IPV vaccine to date and introductions planned according to Gavi eligibility status Data source: WHO/IVB Database, as of 07 January 2016 Map production Immunization Vaccines and Biologicals (IVB), World Health Organization Date of slide: 7 January 2016 The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2016. All rights reserved. Introduced to date (149 countries or 76.8%) Gavi countries with formal commitment to introduce in 2016 (32 countries or 16.5%) Non Gavi countries with formal commitment to introduce in 2016 (13 countries or 6.7%) Not available Not applicable Since January 2013, the following countries have introduced IPV: Kazakhstan, Peru & Singapore (July 2013); Micronesia (August 2013); Libya (April 2014); Albania & Panama (May 2014); Nepal & Tunisia (September 2014); Philippines (October 2014); China (December 2014); Comoros, Senegal & Serbia (January 2015); Colombia & Nigeria (February 2015); Bangladesh & Maldives (March 2015); DR Congo, DPR Korea & The Gambia (April 2015); Madagascar (May 2015); Cote d'Ivoire, Grenada, Kiribati, Morocco, St Vincent and the Grenadines & Sudan (June 2015); Bhutan, Cameroon, Niger, Pakistan, Philippines & Sri Lanka (July 2015); Benin, Chad, Papua New Guinea, The Former Yug. Rep. of Macedonia (August 2015); Afghanistan, CAR, Dominica, Guyana, Iran, Jamaica, Seychelles & Solomon Islands (September 2015); Bahamas, Lao People's Dem Rep, Nauru, Samoa (October 2015); Antigua and Barbuda, Botswana, Burundi, Cook Islands, Guinea, India, Mauritania, Mauritius, Mozambique, Namibia, Nicaragua, St Lucia, Suriname, Tuvalu, Vanuatu & Yemen (November 2015); Algeria, Belize, Cambodia, Dominical Rep, Ecuador, Ethiopia, Fiji, Gabon, Georgia, Honduras, Kenya, Myanmar, S. Sudan, Thailand, Tonga & Trinidad & Tobago (December 2015)

5. 5 |5 | 45 countries introducing IPV between 7 January and September 2016 Tier 1 countries are countries with cVDPV2 transmission or cVDPV2 reported since 2000 & WPV endemic countries Tier 2 countries are countries with cVDPV 1/3 since 2000 or large /medium size countries with DTP3 coverage <80% in the past 3 years as per WUENIC Data source: WHO/IVB Database, as of 07 January 2016 Map production Immunization Vaccines and Biologicals (IVB), World Health Organization Jan-16Feb-16Apr-16After April-16 ArgentinaAzerbaijanCabo VerdeAngola BoliviaDjiboutiArmenia Chile EgyptBurkina Faso Congo Equatorial GuineaEritrea Cuba Guinea-BissauGhana El Salvador LesothoIndonesia Guatemala Sao Tome & PrincipeKyrgyzstan Haiti SwazilandLiberia Iraq Malawi Mali Mongolia Paraguay Rep. of Moldova Saint Kitts and Nevis Rwanda Timor-Leste Sierra Leone Uganda Tajikistan Venezuela Togo Turkmenistan United Rep. of Tanzania Uzbekistan Viet Nam Zambia Zimbabwe 151821 Legend Tier 2 countries

6. 6 |6 | Tier 1 and 2 Countries using IPV vaccine to date and formal decision to introduce Tier 1 countries are countries with cVDPV2 transmission or cVDPV2 reported since 2000 & WPV endemic countries Tier 2 countries are countries with cVDPV 1/3 since 2000 or large /Medium size countries with DTP3 coverage <80% in the past 3 years as per WUENIC Data source: WHO/IVB Database, as of 07 January 2016, based on 36 tier 1 & 2 countries Map production Immunization Vaccines and Biologicals (IVB), World Health Organization Date of slide: 7 January 2016 The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2016. All rights reserved. Introduction to date (27 countries or 75%) (9 countries or 25%) Formal commitment to introduce in 2016 (158 countries ) Since January 2013, the following Tier 1 and 2 countries have introduced IPV: The Philippines (October 2014), China (December 2014), Nigeria (February 2015), DR Congo (April 2015), Madagascar (May 2015), Cameroon, Niger and Pakistan (July 2015); Benin, Chad and Papua New Guinea (August 2015); Afghanistan and CAR (September 2015); Lao People's Democratic Republic (October 2015); Guinea, India, Mauritania, Mozambique, Somalia & Yemen (November 2015); Cambodia, Dominican Rep., Ethiopia, Gabon, Kenya, Myanmar & S. Sudan (December 2015) Not applicable / Not available / Not Tier 1 or 2 countries

7. 7 |7 | Middle Income Countries using IPV vaccine to date and formal decision to introduce Data source: WHO/IVB Database, as of 07 January 2016 based on 100 middle income countries (MIC) as per last World Bank classification Map production Immunization Vaccines and Biologicals (IVB), World Health Organization Date of slide: 7 January 2016 The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2016. All rights reserved. Introduced to date (74 countries or 74%) Formal commitment to introduce in 2016 (26 countries or 26%) Since January 2013, the following MIC have introduced IPV: Kazakhstan (July 2013); Peru (July 2013); Libya (March 2014); Albania (May 2014); Panama (July 2014); Tunisia (September 2014); Philippines (October 2014); China (December 2014); Senegal (January 2015); Serbia (January 2015); Colombia (February 2015); Maldives (March 2015) and Cote d'Ivoire, Kiribati, Morocco, St Vincent and the Grenadines & Sudan (June 2015); Bhutan, Cameroon, Pakistan & Sri Lanka (July 2015); Papua New Guinea & the former Yugoslav Rep. of Macedonia (August 2015); Dominica, Guyana, Iran, Jamaica & Solomon Islands (September 2015); Lao People's Democratic Rep & Samoa (October 2015); Botswana, India, Mauritania, Mauritius, Namibia, Nicaragua, St Lucia, Tuvalu, Vanuatu & Yemen (November 2015); Algeria, Belize, Dominican Rep, Ecuador, Fiji, Gabon, Georgia, Honduras, Kenya, Myanmar, Thailand & Tonga (December 2015) Not available / Not applicable / Non MIC countries

8. 8 |8 | Overview of Global birth cohort by IPV status/tier (100% = 136.1million births in 2015) Data source: WHO/IVB Database, as of 07 January 2016 and United Nations, Department of Economic and Social Affairs, Population Division (2015). World Population Prospects: The 2015 Revision IPV – using Formal commitment to introduce in 2016 before tOPV/bOPV switch Introduction delayed after April 2016 due to global IPV vaccine shortage

9. 9 |9 | bOPV registration status for routine immunization Data source: WHO/IVB Database, as of 07 January 2016 based on 148 OPV user countries and 7 Territories Map production Immunization Vaccines and Biologicals (IVB), World Health Organization Date of slide: 7 January 2016 The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2016. All rights reserved. Approval for use(115 countries or 79%) Review in progress(17 countries or 12%) Pending submission (13 countries or 9%) Not available/ non switch countries (46 countries) + 3 countries switching from tOPV to IPV Not applicable (switch area territories)